Xilio Therapeutics Inc (XLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 09-2020 | |
| Cash Flows From Operating Activities | ||
| Net Income | -55,219 | -34,447 |
| Depreciation Amortization | 1,065 | 724 |
| Accounts payable and accrued liabilities | N/A | 338 |
| Other Working Capital | 14,320 | 6,176 |
| Other Operating Activity | 3,743 | 3,823 |
| Operating Cash Flow | $-36,091 | $-23,386 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -2,188 | -2,080 |
| Investing Cash Flow | $-2,188 | $-2,080 |
| Cash Flows From Financing Activities | ||
| Debt Repayment | N/A | -71 |
| Common Stock Issued | N/A | 6 |
| Other Financing Activity | 10,029 | 9,969 |
| Financing Cash Flow | $10,029 | $9,904 |
| Beginning Cash Position | 49,039 | 49,039 |
| End Cash Position | 20,789 | 33,477 |
| Net Cash Flow | $-28,250 | $-15,562 |
| Free Cash Flow | ||
| Operating Cash Flow | -36,091 | -23,386 |
| Capital Expenditure | N/A | -2,080 |
| Free Cash Flow | -36,091 | -25,466 |